Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls. — CFSMEATLAS
Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls.
Kingdon, Caroline C, Bowman, Erinna W, Curran, Hayley et al. · PharmacoEconomics - open · 2018 · DOI
Quick Summary
This study compared how much ME/CFS affects people's daily lives compared to people with multiple sclerosis and healthy people. Researchers found that people with ME/CFS reported significantly worse physical function, ability to work, and social activities than the other two groups. People with ME/CFS also worked fewer hours and earned less money, showing the real-world impact of the illness on their lives.
Why It Matters
This research provides objective evidence that ME/CFS causes severe disability comparable to or exceeding that of multiple sclerosis, challenging historical misconceptions that have led to under-recognition and discrimination. The findings support advocacy for better clinical recognition, patient support, and research funding. The study quantifies economic burden through employment and income data, demonstrating costs to individuals and society that justify investment in treatment development.
Observed Findings
People with ME/CFS scored significantly lower than both PWMS and healthy controls on the SF-36v2™ across nearly all measured domains
People with ME/CFS showed the largest disparities in Physical Component Summary and Role Physical functioning scores
The Mental Health domain showed the smallest differences between ME/CFS and comparison groups
Participants with ME/CFS reported working fewer hours and earning lower incomes than PWMS and healthy controls
Using SF-36v2™ as a disability proxy, people with ME/CFS demonstrated greater functional impairment than people with multiple sclerosis
Inferred Conclusions
ME/CFS causes measurable disability that exceeds that documented in MS, contradicting historical under-recognition of the disease
The employment and income reductions directly reflect the functional limitations captured in SF-36v2™ scores, confirming real-world impact
Healthcare providers should recognize ME/CFS as a serious disabling condition warranting clinical acknowledgment and patient advocacy
Research and intervention strategies must address the substantial individual and societal costs of ME/CFS
Remaining Questions
How do ME/CFS, MS, and healthy control populations differ in the specific mechanisms driving physical versus cognitive limitations?
What This Study Does Not Prove
This study does not establish what causes the functional limitations in ME/CFS or whether specific biological mechanisms differ from MS. It cannot prove that ME/CFS is more disabling in general populations, as biobank participants may differ from the broader ME/CFS population. The cross-sectional design cannot show how functional status changes over time or identify factors that predict better or worse outcomes.